Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA® (linagliptin tablets), for oral useInitial U.S. Approval: 2011
Medication labelWhy this: Advisory · dailymed-prescription
TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use TRADJENTA is not recommended in patients with type 1 diabetes mellitus as it would not be effective. TRADJENTA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRADJENTA [see Warnings and Precautions (5.1)].
- generic_name
- linagliptin
- product_names
- linagliptin
- ndc
- 55154-0410, 0597-0140, 55154-0410-8
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en